• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

桥本氏病的发病机制标志物——综述

Pathogenesis Markers of Hashimoto's Disease-A Mini Review.

机构信息

Department of General Surgery, Third People's Hospital of Dalian, Dalian Medical University, 116033, Dalian, Liaoning, China.

Department of Central Laboratory, Third People's Hospital of Dalian, Dalian Medical University, 116033, Dalian, Liaoning, China.

出版信息

Front Biosci (Landmark Ed). 2022 Oct 31;27(10):297. doi: 10.31083/j.fbl2710297.

DOI:10.31083/j.fbl2710297
PMID:36336870
Abstract

Hashimoto's thyroiditis (HT) is the most common autoimmune disease involving the thyroid gland. HT often clinically manifest as hypothyroidism due to the destruction of thyroid cells mediated by humoral and cellular immunity. The pathogenesis of HT is a complex process in which environmental factors, hereditary inclination, trace elements immune factors, cytokines, and DNA and miRNA all play an important role. Herein, we summarize the precision factors involved in the pathogenesis of HT and offer an update over the past 5 years to provide a theoretical basis for further investigation of the relevant targets for HT treatment.

摘要

桥本甲状腺炎(HT)是最常见的甲状腺自身免疫性疾病。由于体液和细胞免疫介导的甲状腺细胞破坏,HT 常表现为临床甲状腺功能减退症。HT 的发病机制是一个复杂的过程,环境因素、遗传倾向、微量元素、免疫因素、细胞因子、DNA 和 miRNA 都起着重要作用。本文总结了 HT 发病机制中的精准因素,并对过去 5 年的研究进展进行了综述,为进一步研究 HT 的相关治疗靶点提供理论依据。

相似文献

1
Pathogenesis Markers of Hashimoto's Disease-A Mini Review.桥本氏病的发病机制标志物——综述
Front Biosci (Landmark Ed). 2022 Oct 31;27(10):297. doi: 10.31083/j.fbl2710297.
2
Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation.桥本甲状腺炎:发病机制、诊断方案、治疗策略及潜在恶变更新。
Autoimmun Rev. 2020 Oct;19(10):102649. doi: 10.1016/j.autrev.2020.102649. Epub 2020 Aug 15.
3
[Risk factors and pathogenesis of Hashimoto's thyroiditis].[桥本甲状腺炎的危险因素及发病机制]
Medicina (Kaunas). 2009;45(7):574-83.
4
Therapeutic effect of mesenchymal stem cell on Hashimoto's thyroiditis in a rat model by modulating Th17/Treg cell balance.间充质干细胞通过调节 Th17/Treg 细胞平衡对桥本甲状腺炎大鼠模型的治疗作用。
Autoimmunity. 2020 Feb;53(1):35-45. doi: 10.1080/08916934.2019.1697689. Epub 2019 Dec 3.
5
Association of established hypothyroidism-associated genetic variants with Hashimoto's thyroiditis.已确定的与甲状腺功能减退症相关的遗传变异与桥本甲状腺炎的关联。
J Endocrinol Invest. 2017 Oct;40(10):1061-1067. doi: 10.1007/s40618-017-0660-8. Epub 2017 Apr 5.
6
An update on the pathogenesis of Hashimoto's thyroiditis.桥本甲状腺炎发病机制的研究进展。
J Endocrinol Invest. 2021 May;44(5):883-890. doi: 10.1007/s40618-020-01477-1. Epub 2020 Dec 17.
7
Serum metabolomic analysis in patients with Hashimoto's thyroiditis.桥本甲状腺炎患者的血清代谢组学分析。
Front Endocrinol (Lausanne). 2022 Dec 22;13:1046159. doi: 10.3389/fendo.2022.1046159. eCollection 2022.
8
Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis.白癜风与桥本甲状腺炎:以临床表现、生化共性及自身免疫/氧化应激介导的毒性发病机制相联系的自身免疫性疾病。
Med Hypotheses. 2019 Jul;128:69-75. doi: 10.1016/j.mehy.2019.05.010. Epub 2019 May 14.
9
Hashimoto's thyroiditis and coexisting disorders in correlation with HLA status-an overview.桥本甲状腺炎与 HLA 相关性共存疾病概述。
Wien Med Wochenschr. 2023 Feb;173(1-2):41-53. doi: 10.1007/s10354-021-00879-x. Epub 2021 Sep 15.
10
Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?桥本甲状腺炎与甲状腺乳头状癌:它们在免疫学上有关联吗?
Trends Endocrinol Metab. 2014 Dec;25(12):656-64. doi: 10.1016/j.tem.2014.09.001. Epub 2014 Oct 9.

引用本文的文献

1
Bidirectional Mendelian randomization analysis of the causal relationship between inflammatory bowel disease and Hashimoto thyroiditis.炎症性肠病与桥本甲状腺炎因果关系的双向孟德尔随机化分析。
Medicine (Baltimore). 2025 Aug 29;104(35):e44049. doi: 10.1097/MD.0000000000044049.
2
Effects of sphingolipid metabolism related genes-SPTLC1, ORMDL3, SPHK1 and S1PR3 polymorphisms on susceptibility to hashimoto's thyroiditis.鞘脂代谢相关基因-SPTLC1、ORMDL3、SPHK1和S1PR3多态性对桥本甲状腺炎易感性的影响。
J Endocrinol Invest. 2025 Aug 9. doi: 10.1007/s40618-025-02666-6.
3
Quantitative Multi-Parameter MRI Evaluation of Hashimoto's Thyroiditis Changes After Dietary Interventions.
饮食干预后桥本甲状腺炎变化的定量多参数磁共振成像评估
Med Sci Monit. 2025 Jul 10;31:e947862. doi: 10.12659/MSM.947862.
4
Thyroid dysfunction in Hashimoto's thyroiditis: a pilot study on the putative role of miR-29a and TGFβ1.桥本甲状腺炎中的甲状腺功能障碍:miR-29a 和 TGFβ1 作用的初步研究。
Endocrine. 2024 Dec;86(3):1090-1096. doi: 10.1007/s12020-024-03965-3. Epub 2024 Jul 17.
5
The Role of the Immune System in the Course of Hashimoto's Thyroiditis: The Current State of Knowledge.免疫系统在桥本甲状腺炎病程中的作用:现有知识状况。
Int J Mol Sci. 2024 Jun 23;25(13):6883. doi: 10.3390/ijms25136883.
6
The relationship of peripheral blood lncRNA-PVT1 and miR-146a levels with Th17/Treg cytokines in patients with Hashimoto's thyroiditis and their clinical significance.桥本甲状腺炎患者外周血 lncRNA-PVT1 和 miR-146a 水平与 Th17/Treg 细胞因子的关系及其临床意义。
Biomol Biomed. 2024 Sep 6;24(5):1170-1177. doi: 10.17305/bb.2024.10237.
7
Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis.肠道微生物群调节肠道-甲状腺轴:改善桥本甲状腺炎的新曙光。
Clin Exp Med. 2024 Feb 22;24(1):39. doi: 10.1007/s10238-024-01304-4.
8
Network Pharmacology Studies on the Molecular Mechanism of Hashimoto's Thyroiditis Treated with Shutiao Qiji Decoction.基于网络药理学探讨芍芪杞积汤治疗桥本甲状腺炎的分子机制
Comb Chem High Throughput Screen. 2024;27(19):2899-2911. doi: 10.2174/0113862073259714231012070100.
9
Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome.多囊卵巢综合征不孕症的免疫和代谢原因
Biomedicines. 2023 May 28;11(6):1567. doi: 10.3390/biomedicines11061567.
10
Association of Pro-Inflammatory Cytokines with Vitamin D in Hashimoto's Thyroid Autoimmune Disease.促炎细胞因子与桥本甲状腺自身免疫性疾病中维生素 D 的关系。
Medicina (Kaunas). 2023 Apr 28;59(5):853. doi: 10.3390/medicina59050853.